Evidence map›Paper›PMID 32486445›Full record

ReviewInternational journal of molecular sciences2020

Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.

Tripti Khare, Sushesh Srivatsa Palakurthi, Brijesh M Shah, Srinath Palakurthi, Sharad Khare

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Promising protective treatment potential of endophytic bacteriumJournal of Zhejiang University. Science. B · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tripti KhareDivision of Gastroenterology and Hepatology, Department of Medicine, University of Missouri, Columbia, MO 65212, USA.
Sushesh Srivatsa PalakurthiDepartment of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M University, Kingsville, TX 78363, USA.
Brijesh M ShahDepartment of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M University, Kingsville, TX 78363, USA.
Srinath PalakurthiDepartment of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M University, Kingsville, TX 78363, USA.ORCID 0000-0002-9509-9511
Sharad KhareDivision of Gastroenterology and Hepatology, Department of Medicine, University of Missouri, Columbia, MO 65212, USA.
Texas A&M University – Kingsville · USHarry S. Truman Memorial Veterans' Hospital · USUniversity of Missouri · US

Funding

Colorectal Cancer: Characterization of a new Cre-LoxP ModelR03CA216160 · NCI · UNIVERSITY OF MISSOURI-COLUMBIA · PI KHARE, SHARAD · 2017 to 2018
$122k
NCI NIH HHS 1RO3CA216160The University of Missouri, School of Medicine Bridge Funding F2373, C2638054, EM054U.S. Department of Veterans Affairs 2I01BX000824
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NanomedicineAnimalsBenzoquinonesBiological ProductsBiomimeticsCaffeic AcidsCurcuminCytokinesExosomesHumansInflammationInflammatory Bowel DiseasesInsectaMacromolecular SubstancesOxidative StressPhenylethyl Alcohol3,3',4,5'-tetrahydroxystilbeneBenzoquinonesBiological Productscaffeic acid phenethyl esterCaffeic AcidsCurcuminCytokinesembelinMacromolecular SubstancesPhenylethyl AlcoholPhytochemicalsPlant ExtractsPolysaccharidesQuercetinResveratrolStilbenesTranscription FactorsVasoactive Intestinal PeptideCrohn’s diseaseinflammationinflammatory bowel diseasemacromoleculesnanomedicinenanoparticlesphytochemicalsulcerative colitis

Identifiers

PMID32486445
PMCPMC7312938
OpenAlexW3032190414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.